{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:48Z","timestamp":1791862248572,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.pec.2020.03.018","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T12:26:31Z","timestamp":1584707191000},"page":"1724-1735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Patients\u2019 understanding of oncology clinical endpoints: A literature review"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-290X","authenticated-orcid":false,"given":"Vanessa","family":"Boudewyns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G.","family":"Southwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica T.","family":"DeFrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Ferriola-Bruckenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Halpern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie C.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-7554","authenticated-orcid":false,"given":"Helen W.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pec.2020.03.018_bib0005","series-title":"Novel Drug Approvals for 2018","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.pec.2020.03.018_bib0010","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2015.61.6706","article-title":"American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options","volume":"33","author":"Schnipper","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pec.2020.03.018_bib0015","series-title":"Guidance for Industry: Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics","author":"Food and Drug Administration","year":"2019"},{"key":"10.1016\/j.pec.2020.03.018_bib0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jamaoncol.2017.5618","article-title":"A 25-year experience of us food and drug administration accelerated approval of malignant hematology and oncology drugs and biologics: a review","volume":"4","author":"Beaver","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.pec.2020.03.018_bib0025","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.mayocp.2016.02.012","article-title":"Strength of validation for surrogate end points used in the US Food and Drug Administration\u2019s approval of oncology drugs","volume":"91","author":"Kim","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.pec.2020.03.018_bib0030","doi-asserted-by":"crossref","first-page":"509","DOI":"10.6061\/clinics\/2014(08)02","article-title":"Treatment priorities in oncology: do we want to live longer or better?","volume":"69","author":"Marta","year":"2014","journal-title":"Clinics"},{"key":"10.1016\/j.pec.2020.03.018_bib0035","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","article-title":"Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer","volume":"24","author":"Matsuyama","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pec.2020.03.018_bib0040","series-title":"Oncology Marketing Goes Prime Time: Pharma Brands Move to DTC Advertising to Capture Market Share","author":"McCaffrey","year":"2017"},{"key":"10.1016\/j.pec.2020.03.018_bib0045","series-title":"Rx: Cancer TV Commercials","author":"iSpot.tv","year":"2018"},{"key":"10.1016\/j.pec.2020.03.018_bib0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.lungcan.2012.01.016","article-title":"Patients\u2019 preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis","volume":"77","author":"Bridges","year":"2012","journal-title":"Lung Cancer."},{"key":"10.1016\/j.pec.2020.03.018_bib0055","first-page":"417","article-title":"Knowledge of treatment intent among patients with advanced cancer: a longitudinal study","volume":"14","author":"Craft","year":"2005","journal-title":"Eur. J. Cancer Care (Engl)"},{"key":"10.1016\/j.pec.2020.03.018_bib0060","first-page":"237","article-title":"Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits","volume":"25","author":"Fallowfield","year":"2017","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.pec.2020.03.018_bib0065","first-page":"3941","article-title":"Do drugs offering only PFS maintain quality of life sufficiently from a patient\u2019s perspective? Results from AVALPROFS (assessing the\u2019 VALue\u2019 to patients of PROgression Free Survival) study","volume":"26","author":"Jenkins","year":"2018","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.pec.2020.03.018_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/865101","article-title":"Which metrics are appropriate to describe the value of new cancer therapies?","volume":"2015","author":"Johnson","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.pec.2020.03.018_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1634\/theoncologist.2017-0257","article-title":"Individual trade-offs between possible benefits and risks of cancer treatments: results from a stated preference study with patients with multiple myeloma","volume":"23","author":"Postmus","year":"2018","journal-title":"Oncologist."},{"key":"10.1016\/j.pec.2020.03.018_bib0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/0272989X17691953","article-title":"Marketing authorization procedures for advanced cancer drugs: exploring the views of patients, oncologists, healthcare decision makers, and citizens in France","volume":"37","author":"Protiere","year":"2017","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.pec.2020.03.018_bib0085","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1200\/JCO.2010.32.4459","article-title":"Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care","volume":"29","author":"Temel","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pec.2020.03.018_bib0090","first-page":"10","article-title":"The AVALPROFS study: assessing the VALue of PROgression free survival","volume":"24","author":"Catt","year":"2015","journal-title":"Psychooncology."},{"key":"10.1016\/j.pec.2020.03.018_bib0095","first-page":"22","article-title":"Patient preferences for metastatic renal cell carcinoma treatments: a discrete-choice experiment","volume":"118","author":"Gonz\u00e1lez","year":"2016","journal-title":"BJU Int."},{"key":"10.1016\/j.pec.2020.03.018_bib0100","series-title":"Paper Presented at: ASCO Quality Care Symposium; September 28","article-title":"Imaging progression-free survival: how much does it matter to patients?","author":"O\u2019Donnell","year":"2018"},{"key":"10.1016\/j.pec.2020.03.018_bib0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1359-6349(10)70094-X","article-title":"A comparison of physician and patient perceptions of clinically important endpoints in the treatment of metastatic breast cancer (MBC)","volume":"8","author":"Sheik-Yousouf","year":"2010","journal-title":"Eur J Cancer Suppl."},{"key":"10.1016\/j.pec.2020.03.018_bib0110","first-page":"36","article-title":"Prognostic understanding in acute leukemia: patient-physician differences","author":"Shimer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.pec.2020.03.018_bib0115","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/bjc.2013.182","article-title":"Class, race and ethnicity and information avoidance among cancer survivors","volume":"108","author":"McCloud","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.pec.2020.03.018_bib0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10810730.2010.499985","article-title":"Health literacy: what is it?","volume":"15","author":"Berkman","year":"2010","journal-title":"J. Health Commun."},{"key":"10.1016\/j.pec.2020.03.018_bib0125","series-title":"Misinformation and Mass Audiences","first-page":"35","article-title":"Awareness of misinformation in health-related advertising: a narrative review of the literature","author":"Boudewyns","year":"2018"},{"key":"10.1016\/j.pec.2020.03.018_bib0130","series-title":"Patient-centered Communication in Cancer Care: Promoting Healing and Reducing Suffering. NIH Report No. 07-6225","author":"Epstein","year":"2007"},{"key":"10.1016\/j.pec.2020.03.018_bib0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.35680\/2372-0247.1167","article-title":"Patient experiences of cancer care: scoping review, future directions, and introduction of a new data resource: surveillance Epidemiology and End Results-Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS)","volume":"4","author":"Mollica","year":"2017","journal-title":"Patient Exp. J."},{"key":"10.1016\/j.pec.2020.03.018_bib0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1634\/theoncologist.2018-0761","article-title":"Patient\u2010friendly language to facilitate treatment choice for patients with cancer","volume":"24","author":"Kim","year":"2019","journal-title":"Oncologist"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073839912030152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073839912030152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:28:51Z","timestamp":1760034531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073839912030152X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S073839912030152X"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2020.03.018","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients\u2019 understanding of oncology clinical endpoints: A literature review","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2020.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}